Zobrazeno 1 - 10
of 774
pro vyhledávání: '"Yoshihiro YAMAMOTO"'
Autor:
Yoshihiro Yamamoto, Daisuke Shibahara, Taro Mori, Kohei Otsubo, Yoshimasa Shiraishi, Yasuto Yoneshima, Eiji Iwama, Kentaro Tanaka, Yoshinao Oda, Isamu Okamoto
Publikováno v:
Thoracic Cancer, Vol 15, Iss 13, Pp 1106-1111 (2024)
Abstract Tracheomediastinal fistula is a rare but life‐threatening complication of cancer. We report a case of tracheomediastinal fistula induced by concurrent chemoradiotherapy in limited stage small cell lung cancer. Despite the treatment respons
Externí odkaz:
https://doaj.org/article/3dd6dd6ee9bd48c088fd5ca776e5f172
Autor:
Ae Kawaguchi, Kentaro Nagaoka, Hitoshi Kawasuji, Toshiomi Kawagishi, Takamasa Fuchigami, Kaho Ikeda, Jun-Ichi Kanatani, Tomoaki Doi, Kazunori Oishi, Yoshihiro Yamamoto
Publikováno v:
International Journal of Infectious Diseases, Vol 148, Iss , Pp 107246- (2024)
Case 1: A 71-year-old man was admitted to our hospital with progressive fever and dyspnea, which had developed three days after the onset of COVID-19. Initial chest computed tomography (CT) revealed a pulmonary lesion consistent with a secondary bact
Externí odkaz:
https://doaj.org/article/9be7509ecd554720a01637c7228fa620
Autor:
Akio Miyakoshi, Hideki Niimi, Tomohiro Ueno, Masahiro Wakasugi, Yoshitsugu Higashi, Yuki Miyajima, Masashi Mori, Homare Tabata, Hiroshi Minami, Akinori Takaoka, Atsushi Hayashi, Yoshihiro Yamamoto, Isao Kitajima
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Sepsis is life-threatening organ dysfunction and is considered a major cause of health loss. However, since the current biomarkers of sepsis reflect the host’s immune response to microorganisms, they would inevitably cause a time-lag. This
Externí odkaz:
https://doaj.org/article/080df6a060674ba4b2287656c06faa19
Autor:
Hitoshi Kawasuji, Yoshitomo Morinaga, Kentaro Nagaoka, Hideki Tani, Yoshihiro Yoshida, Hiroshi Yamada, Yusuke Takegoshi, Makito Kaneda, Yushi Murai, Kou Kimoto, Hideki Niimi, Yoshihiro Yamamoto
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundAcute immune responses to coronavirus disease 2019 (COVID-19) are influenced by variants, vaccination, and clinical severity. Thus, the outcome of these responses may differ between vaccinated and unvaccinated patients and those with and wi
Externí odkaz:
https://doaj.org/article/d750f7ec821645768008d4c89515a818
Autor:
Ryusei Uchio, Chinatsu Okuda-Hanafusa, Haruka Sakaguchi, Ryosuke Saji, Koutarou Muroyama, Shinji Murosaki, Yoshihiro Yamamoto, Yoshitaka Hirose
Publikováno v:
Frontiers in Nutrition, Vol 11 (2024)
The spice turmeric, which has the Latin name Curcuma longa (C. longa), has various physiological effects. This study evaluated the effects of a hot water mixture with supercritical carbon dioxide C. longa extracts, CLE, and the potential active compo
Externí odkaz:
https://doaj.org/article/b7e141c4d01c4c4497e1a9c8067a6fc8
Autor:
Mahoko Ikeda, Shu Okugawa, Kosuke Kashiwabara, Takashi Moritoyo, Yoshiaki Kanno, Daisuke Jubishi, Hideki Hashimoto, Koh Okamoto, Kenji Tsushima, Yasuki Uchida, Takahiro Mitsumura, Hidetoshi Igari, Takeya Tsutsumi, Hideki Araoka, Kazuhiro Yatera, Yoshihiro Yamamoto, Yuki Nakamura, Amato Otani, Marie Yamashita, Yuji Wakimoto, Takayuki Shinohara, Maho Adachi-Katayama, Tatsunori Oyabu, Aoi Kanematsu, Sohei Harada, Yuichiro Takeshita, Yasutaka Nakano, Yasunari Miyazaki, Seiichiro Sakao, Makoto Saito, Sho Ogura, Kei Yamasaki, Hitoshi Kawasuji, Osamu Hataji, Jun-Ichiro Inoue, Yasuyuki Seto, Kyoji Moriya
Publikováno v:
International Journal of Infectious Diseases, Vol 128, Iss , Pp 355-363 (2023)
Objectives: To evaluate the efficacy and safety of nafamostat combined with favipiravir for the treatment of COVID-19. Methods: We conducted a multicenter, randomized, single-blind, placebo-controlled, parallel assignment study in hospitalized patien
Externí odkaz:
https://doaj.org/article/b44f924622ed47a1904be3da3e84d112
Autor:
Taiga Miyazaki, Naoki Hosogaya, Yuri Fukushige, Sachiko Takemori, Shinpei Morimoto, Hiroshi Yamamoto, Makoto Hori, Yoshihito Ozawa, Yuki Shiko, Yosuke Inaba, Tomoya Kurokawa, Hideki Hanaoka, Shoya Iwanami, Kwangsu Kim, Shingo Iwami, Koichi Watashi, Ken Miyazawa, Takashi Umeyama, Satoshi Yamagoe, Yoshitsugu Miyazaki, Takaji Wakita, Makoto Sumiyoshi, Tatsuro Hirayama, Koichi Izumikawa, Katsunori Yanagihara, Hiroshi Mukae, Hitoshi Kawasuji, Yoshihiro Yamamoto, Norihito Tarumoto, Hiroshi Ishii, Hideaki Ohno, Kazuhiro Yatera, Hiroshi Kakeya, Yoshiko Kichikawa, Yasuyuki Kato, Tetsuya Matsumoto, Makoto Saito, Hiroshi Yotsuyanagi, Shigeru Kohno
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 3 (2023)
ABSTRACT Nelfinavir, an orally administered inhibitor of human immunodeficiency virus protease, inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro. We conducted a randomized controlled trial to evaluate
Externí odkaz:
https://doaj.org/article/0a380e871da94f7abcec22d99a173a53
Autor:
Yuki Miyajima, Hideki Niimi, Tomohiro Ueno, Atsushi Matsui, Yoshitsugu Higashi, Nozomi Kojima, Mari Kono, Yosuke Iwasaki, Kentaro Nagaoka, Yoshihiro Yamamoto, Isao Kitajima
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundCell population data (CPD) parameters related to neutrophils, such as fluorescent light intensity (NE-SFL) and fluorescent light distribution width index (NE-WY), have emerged as potential biomarkers for sepsis. However, the diagnostic impl
Externí odkaz:
https://doaj.org/article/3322511b88db4d6dbdb257f944772b93
Autor:
Hiroshi Yamada, So-Ichiro Sasaki, Hideki Tani, Mayu Somekawa, Hitoshi Kawasuji, Yumiko Saga, Yoshihiro Yoshida, Yoshihiro Yamamoto, Yoshihiro Hayakawa, Yoshitomo Morinaga
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-6 (2022)
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a biosafety level (BSL)-3 pathogen; therefore, its research environment is limited. Pseudotyped viruses that mimic the infection of SARS-CoV-2 have been widely used for in vitro
Externí odkaz:
https://doaj.org/article/30bb960f7004482ebb6918cc9b1b8e70
Autor:
Yosuke Mitani, Shinya Ohashi, Osamu Kikuchi, Yukie Nakai, Tomomi Ida, Ayaka Mizumoto, Yoshihiro Yamamoto, Tomoki Saito, Shigeki Kataoka, Junichi Matsubara, Atsushi Yamada, Masashi Kanai, Shigemi Matsumoto, Hiroaki Sakai, Kiyotsugu Yoshikawa, Eijiro Nakamura, Manabu Muto
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract Clinical cancer genome sequencing detects oncogenic variants that are potential targets for cancer treatment, but it also detects variants of unknown significance. These variants may interact with each other to influence tumor pathophysiolog
Externí odkaz:
https://doaj.org/article/a5a28560b24a488aa789094fa8f44f21